<?xml version='1.0' encoding='utf-8'?>
<document id="25425315"><sentence text="Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy."><entity charOffset="14-30" id="DDI-PubMed.25425315.s1.e0" text="N-acetylcysteine" /></sentence><sentence text="Bromelain and N-acetylcysteine are two natural, sulfhydryl-containing compounds with good safety profiles which have been investigated for their benefits and application in health and disease for more than fifty years"><entity charOffset="14-30" id="DDI-PubMed.25425315.s2.e0" text="N-acetylcysteine" /><entity charOffset="48-58" id="DDI-PubMed.25425315.s2.e1" text="sulfhydryl" /><pair ddi="false" e1="DDI-PubMed.25425315.s2.e0" e2="DDI-PubMed.25425315.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25425315.s2.e0" e2="DDI-PubMed.25425315.s2.e1" /></sentence><sentence text=" As such, the potential values of these agents in cancer therapy have been variably reported in the literature" /><sentence text=" In the present study, the efficacy of bromelain and N-acetylcysteine in single agent and combination treatment of human gastrointestinal carcinoma cells was evaluated in vitro and the underlying mechanisms of effect were explored"><entity charOffset="53-69" id="DDI-PubMed.25425315.s4.e0" text="N-acetylcysteine" /></sentence><sentence text="" /><sentence text="The growth-inhibitory effects of bromelain and N-acetylcysteine, on their own and in combination, on a panel of human gastrointestinal carcinoma cell lines, including MKN45, KATO-III, HT29-5F12, HT29-5M21 and LS174T, were assessed by sulforhodamine B assay"><entity charOffset="47-63" id="DDI-PubMed.25425315.s6.e0" text="N-acetylcysteine" /><entity charOffset="184-193" id="DDI-PubMed.25425315.s6.e1" text="HT29-5F12" /><entity charOffset="209-215" id="DDI-PubMed.25425315.s6.e2" text="LS174T" /><entity charOffset="234-250" id="DDI-PubMed.25425315.s6.e3" text="sulforhodamine B" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e0" e2="DDI-PubMed.25425315.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e0" e2="DDI-PubMed.25425315.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e0" e2="DDI-PubMed.25425315.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e0" e2="DDI-PubMed.25425315.s6.e3" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e1" e2="DDI-PubMed.25425315.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e1" e2="DDI-PubMed.25425315.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e1" e2="DDI-PubMed.25425315.s6.e3" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e2" e2="DDI-PubMed.25425315.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25425315.s6.e2" e2="DDI-PubMed.25425315.s6.e3" /></sentence><sentence text=" Moreover, the influence of the treatment on the expression of a range of proteins involved in the regulation of cell cycle and survival was investigated by Western blot" /><sentence text=" The presence of apoptosis was also examined by TUNEL assay" /><sentence text="" /><sentence text="Bromelain and N-acetylcysteine significantly inhibited cell proliferation, more potently in combination therapy"><entity charOffset="14-30" id="DDI-PubMed.25425315.s10.e0" text="N-acetylcysteine" /></sentence><sentence text=" Drug-drug interaction in combination therapy was found to be predominantly synergistic or additive" /><sentence text=" Mechanistically, apoptotic bodies were detected in treated cells by TUNEL assay" /><sentence text=" Furthermore, Western blot analysis revealed diminution of cyclins A, B and D, the emergence of immunoreactive subunits of caspase-3, caspase-7, caspase-8 and cleaved PARP, withering or cleavage of procaspase-9, overexpression of cytochrome c, reduced expression of anti-apoptotic Bcl-2 and pro-survival phospho-Akt, the emergence of the autophagosomal marker LC3-II and deregulation of other autophagy-related proteins, including Atg3, Atg5, Atg7, Atg12 and Beclin 1" /><sentence text=" These results were more prominent in combination therapy" /><sentence text="" /><sentence text="We report for the first time to our knowledge the growth-inhibitory and cytotoxic effects of bromelain and N-acetylcysteine, in particular in combination, on a panel of gastrointestinal cancer cell lines with different phenotypes and characteristics"><entity charOffset="107-123" id="DDI-PubMed.25425315.s16.e0" text="N-acetylcysteine" /></sentence><sentence text=" These effects apparently resulted from cell cycle arrest, apoptosis and autophagy" /><sentence text=" Towards the development of novel strategies for the enhancement of microscopic cytoreduction, our results lay the basis for further evaluation of this formulation in locoregional approaches to peritoneal surface malignancies and carcinomatosis" /><sentence text="" /></document>